Biotechnology & Inventorship – What You Need To Know

Sponsor: BCLT
Inventorship is the threshold determination for patent rights.  As a result, individuals, research institutions, biotechnology start-ups, venture capitalists, and biopharma collaborators may face significant commercial implications from this determination, potentially with surprising (or even problematic) results.  In this three-part virtual series, BCLT & Greenberg Traurig discuss the law of biotechnology patent inventorship in patent prosecution, trade secret and patent litigation, and commercial transactions. The aim of this virtual speaker series is to educate biotechnology stake holders (scientists, entrepreneurs, funders, and their attorneys) on best practices for determining inventorship and addressing disputes, so that they may conduct their business affairs with greater certainty. For anyone with a stake in a biotechnology invention, this series will help you optimize your rights and reduce your risks.  Don’t miss it!

Generative AI as a Creativity Tool? A Program to Explore Implications

Sponsor: BCLT
Generative Artificial Intelligence (AI) is a widely used disruptive technology. It is, however, far from the first technology to disrupt economic and social paradigms. Societies have adapted to such technologies in the past. This half-day conference will consider how society may adapt to generative AI. Our speakers will consider concerns that have been raised about the dangers of AI and copyright implications of generative, but also some benefits that AI can bring about in terms of new products, services, capabilities, and new opportunities for creative expression.